Boards & Committees - Education
Education Committee MEDICAL DIRECTOR OF EDUCATIONAL AFFAIRS:
Wednesday, April 15, 2015, 12:45 PM - 2:45 PM
Acropolis Congres Centre, Nice, France
In Montreal (April 2013), the Board of Directors unanimously adopted a strategy policy for ISHLT Educational Affairs.
For the , a curriculum process
has been introduced. Designated extra-curricular events and other learning modules will provide complimentary options (separate from the ISHLT Academy).
A conceptual framework and a clear process to align all of the existing and any planned educational activities has been devised. Please take a moment to familiarize yourself with the strategic plan and terminology.
Chris Wigfield MD MD FRCS(C/Th)
Educational Affairs Director, ISHLT
- The overall educational strategy for the Society shall be implemented by the Medical Director of Educational Affairs. The Medical Director of Educational Affairs shall be selected by the Board of Directors following an application and interview process. The term is for 5 years, renewable for one additional year at a time for a maximum term of 10 years. The Medical Director shall receive a stipend of $20,000 per year. The Medical Director shall serve as an ex-officio member of the Board of Directors and as the Chair of the Education Committee.
- The Education Committee shall be chaired by the Medical Director of Educational Affairs. The leader of each Scientific Council Education Workforce shall serve on the Committee.
- The Annual Meeting Scientific Program Chair, the Annual Meeting Scientific Program Chair-Elect, and the Chair(s) of the current and incoming year’s educational activities shall serve on the Committee.
- The Medical Director may create an Education Task Force to address special projects of the Education Committee. The Medical Director may appoint up to five Task Force members to serve two-year terms, renewable once.
- Education Committee and Education Task Force Members may not serve on the Annual Meeting Program Committees.
- Ensure that the educational activities of the Society meet ACCME requirements as well as those of other medical education program accrediting bodies as directed by the Board of Directors.
- Identify the ongoing practice gaps and educational needs of the Society's members.
- Develop strategies and plans for the delivery of educational programs and services that meet the identified educational needs.
- Ensure that planned educational programs and services have content and learning objectives that meet the identified educational needs.
- Evaluate the quality of ISHLT's educational programs and make recommendations for improvements and changes to future content and format.
- Develop criteria to which all ISHLT educational programs must adhere, to include the following: content and speaker selection standards; endorsement of educational programs by other organizations; development of educational programs jointly with other organizations.
- Review educational program proposals developed by the Scientific Councils and make recommendations regarding revisions necessary and/or required to meet ISHLT’s educational standards.
- Refer discipline-specific proposals for educational programs to the appropriate Scientific Council Education Workforce for development into formal proposals.
- Act as liaison between the Scientific Council Education Workforces, the proposed educational program chair(s), and the Board to facilitate the development of well-structured education program proposals to the Board, with appropriate budget proposals.
- Evaluate requests from other organizations for ISHLT to co-sponsor or endorse educational programs and make recommendations to the Board of Directors for action.
- Act as liaison between the Scientific Council Education Workforces and the Annual Meeting Program Committee to facilitate the development of well-structured proposals for the Annual Meeting Program Committee's consideration.
- Act as liaison with the Editor of the Journal of Heart and Lung Transplantation regarding the publication of any proceedings from such meetings.
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois, USA
email@example.comChristopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Cardiothoracic Surgery at the University of Chicago. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.2015 SCIENTIFIC PROGRAM CHAIR:2016 SCIENTIFIC PROGRAM CHAIR:
Newcastle Upon Tyne, UK
firstname.lastname@example.orgAndrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.DEVELOPMENT COMMITTEE CHAIR:
University of Alberta
Edmonton, Alberta, CANADA
email@example.comDr. Lori West is the Director of Heart Transplantation Research and a Professor of Pediatrics, Surgery and Immunology at the University of Alberta - one of the largest heart transplant programs in the world. Dr. West completed her pediatric residency at Harbor-UCLA Medical Center. She trained in pediatric cardiology at the Hospital for Sick Children, Toronto, and subsequently in pediatric transplant cardiology at Pittsburgh Children's Hospital, Loma Linda University Medical Center and Columbia-Presbyterian Children's Hospital. She obtained her PhD for specialized training in transplant immunology research at Oxford University and works in the role of a clinician-scientist.COUNCIL WORKFORCE LEADERS:
University of Michigan Medical School
Ann Arbor, MI, USA
firstname.lastname@example.orgBio coming soon...
University of Alabama at Birmingham
Birmingham, Alabama, USA
email@example.comJosé A. Tallaj, MD, is an Associate Professor, Department of Internal Medicine, at the University of Alabama at Birmingham. He is a specialist in Cardiovascular Medicine, and his clinical interests are transplant cardiology, ventricular assist devices, congestive heart failure and pulmonary hypertension. Dr. Tallaj completed his medical degree at the Pontificia Universidad Catolica Madre y Maestra in Dominican Republic, and residency at Wayne State University in Detroit, Michigan. He completed a fellowship at the University of Alabama at Birmingham where he stayed on faculty. He is currently the Medical Director of the Heart Transplant program.
University of Montréal
St-Luc Hospital, Centre Hospitalier de l'Universite de Montréal (CHUM)
514-890-8000 ext. firstname.lastname@example.orgMe-Linh Luong, MD is an assistant professor of Medicine at the University oF Montreal, Montreal, Canada. Dr. Luong earned her MD at the University of Sherbrooke and subsequently completed her residency in Internal Medicine at University of Montreal. She went on to complete an Infectious Diseases and Medical Microbiology fellowship at McGill University followed by a postgraduate training in Transplant Infectious Diseases at the University of Toronto, Canada. Her main research interests include the epidemiology and outcome of fungal infection in lung transplant recipients, novel diagnostics methods for fungal infections and antifungal treatment.
Rochester, Minnesota, USA
email@example.comJonathan Johnson, MD is an associate professor of Pediatrics at the Mayo Clinic in Rochester, Minnesota, where he is the medical director of the Pediatric Heart Transplant Program. Dr. Johnson received his medical degree from Wayne State University in 2005. He completed training in Pediatric and Adolescent Medicine at the Mayo Clinic in 2008, and subsequently went on to complete subspecialty training in Pediatric Cardiology at Mayo in 2011. Dr. Johnson’s research interests focus on improving clinical outcomes of pediatric heart failure and transplant patients, the use of mTOR inhibitors in the pediatric population, and on novel methods to non-invasively detect allograft rejection. He also serves as co-director of CME programs for the Department of Pediatrics at the Mayo Clinic, and has a particular interest in symposium and meeting development.
University of Alabama at Birmingham
Birmingham, Alabama, USA
firstname.lastname@example.orgDr. Pamboukian completed her MD degree at the University of Toronto, Canada, where she also completed an internal medicine residency. She received a cardiology fellowship at the University of British Columbia, Vancouver, followed by a cardiac transplantation and heart failure fellowship at Rush-Presbyterian/St. Luke’s Medical Center in Chicago, Illinois. Presently, she is Medical Director of the Mechanical Circulatory Support Device Program and co-section head of the Section of Advanced Heart Failure, Cardiac Transplant, Mechanical Circulatory Support and Pulmonary Vascular Disease at the University of Alabama at Bimingham.
Cleveland, OH, USA
email@example.comBio coming soon...
Vanderbilt Children's Hospital
Nashville, Tennessee, USA
firstname.lastname@example.orgDr. Debra Dodd graduated from medical school at The Johns Hopkins University. Her pediatric and pediatric cardiology training was at Vanderbilt Children’s Hospital. Following her training, she remained at Vanderbilt Children’s Hospital where she helped establish a Pediatric Heart Transplant Program at VCH in 1989 and has been Medical Director of the Pediatric Heart Transplant Program since 1993.
The Methodist Hospital
Houston, TX, USA
713-441-6997KLDawson@tmhs.orgBio coming soon...
Hammersmith Hospital, Department of Cardiology
London, UNITED KINGDOM
email@example.comBio coming soon...
Univ of Michigan Health System
Ann Arbor, Michigan, USA
firstname.lastname@example.orgKevin Chan, MD, is Medical Director of Lung Transplantation and Fellowship Program Director in the Division of Pulmonary and Critical Care Medicine at the University of Michigan in Ann Arbor, MI, USA. Dr. Chan received his medical degree from Wayne State University, completed his internal medicine residency at Rush Presbyterian St. Luke’s Medical Center in Chicago, and fellowship in Pulmonary and Critical Care Medicine at the University Of California Los Angeles Center for the Health Sciences.EDUCATION COMMITTEE TASKFORCE MEMBERS:
University of Alberta
Dept of Ped, Lab of Dr. Lori J. West
Edmonton, Alberta, CANADA
email@example.comEsmé Dijke works as a Post-doctoral Fellow at the University of Alberta in Edmonton under the supervision of Dr. Lori West. She graduated cum laude from the Rotterdam University in Rotterdam (Netherlands) with a Bachelor of Applied Sciences degree in Biotechnology. She received her PhD in the laboratory of Dr. Carla Baan and Dr. Willem Weimar at the Erasmus University in Rotterdam, where her doctoral studies focused on the role of regulatory T cells in adult heart transplant recipients. Her research interests are the role of regulatory T cells and B-cell memory in infants and its possible relation to development of tolerance to graft antigens.
Newcastle Upon Tyne, UK
firstname.lastname@example.orgAndrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.
Cedars Sinai Heart Institute
Los Angeles, CA, USA
310-248-8300KobashigawaJ@cshs.orgJon Kobashigawa, MD, is Associate Director for Clinical Affairs, Director of Advanced Heart Disease and Director of the Heart Transplant Program. In addition, he holds the DSL/Thomas D. Gordon Chair in Heart Transplantation Medicine. He also is a clinical professor of medicine and cardiology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He is board certified in internal medicine and cardiovascular disease. After earning his bachelor's at Stanford University, Dr. Kobashigawa earned his medical degree at Mount Sinai School of Medicine in New York. He performed his internship and residency in internal medicine followed by a fellowship in cardiology at the UCLA Medical Center. Dr. Kobashigawa specializes in heart transplantation, advanced heart failure, cardiac catheterization, athletic heart syndrome, sudden cardiac death and valvular heart disease.
University of Pittsburgh/Presbyterian
Pittsburgh, Pennsylvania, USA
email@example.comJeffrey Teuteberg, MD, is an Assistant Professor of Medicine, Associate Director of the Cardiac Transplant Program, and a member of the Heart Failure/Cardiac Transplant section of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Medical Center, where he specializes in the care of patients with advanced cardiomyopathies, cardiac transplantation, ventricular assist devices and pulmonary hypertension. He has particular interests in advanced heart failure and the transition to cardiac transplantation and ventricular assist devices. Dr. Teuteberg graduated from the University of Chicago, Pritzker School of Medicine, in 1992 and remained at the University of Chicago for his Internal Medicine Residency and general Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg received his Heart Failure and Cardiac Transplant training at Brigham and Women's hospital in Boston.
Medical University of Vienna
firstname.lastname@example.orgBio coming soon...